Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter - PubMed (original) (raw)
Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter
Yuping Chen et al. Mol Pharmacol. 2003 Aug.
Abstract
CYP2C19 is an important human drug-metabolizing enzyme that metabolizes a number of clinically used drugs including the antiulcer drug omeprazole, the anxiolytic drug diazepam, the beta-blocker propranolol, the antimalarial drug proguanil, certain antidepressants and barbiturates, and the prototype substrate S-mephenytoin. Previous studies show that compounds such as rifampicin and dexamethasone induce CYP2C19 both in vivo in humans and in vitro in human hepatocytes. This study examines the transcriptional regulation of CYP2C19. Analysis of the CYP2C19 promoter revealed a single constitutive androstane receptor (CAR) binding site (CAR-RE; -1891/-1876 bp) and a glucocorticoid-responsive element (GRE; -1750/-1736 bp). Gel-shift assays showed that CAR-RE binds CAR and pregnane X receptor (PXR). Cotransfection with hCAR, mCAR, or hPXR in HepG2 cells up-regulated transcription of CYP2C19 promoter constructs, whereas mutation of the -1891-bp CAR-RE abolished up-regulation. Expression with hCAR also up-regulated endogenous CYP2C19 mRNA content in HepG2 cells. Androstenol repressed the mCAR-mediated constitutive activation of the CYP2C19 promoter in HepG2 cells, whereas the potent mCAR ligand 1,4-bis[2-3,5-dichloropyridyloxyl)] benzene derepressed this response. Rifampicin produced a modest increase in promoter activity in cells cotransfected with hPXR. Dexamethasone activated the -2.7-kb CYP2C19 promoter constructs in HepG2 cells only in the presence of cotransfected glucocorticoid receptor (GR), whereas the GR antagonist mifepristone inhibits this response. Mutation of the GRE abolishes dexamethasone activation. This is the first study to identify nuclear receptor binding sites (CAR/PXR and GR) in the CYP2C19 promoter and to suggest that these receptors may up-regulate CYP2C19 constitutively and possibly its response to drugs.
Similar articles
- Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site.
Ferguson SS, LeCluyse EL, Negishi M, Goldstein JA. Ferguson SS, et al. Mol Pharmacol. 2002 Sep;62(3):737-46. doi: 10.1124/mol.62.3.737. Mol Pharmacol. 2002. PMID: 12181452 - Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha.
Ferguson SS, Chen Y, LeCluyse EL, Negishi M, Goldstein JA. Ferguson SS, et al. Mol Pharmacol. 2005 Sep;68(3):747-57. doi: 10.1124/mol.105.013169. Epub 2005 Jun 2. Mol Pharmacol. 2005. PMID: 15933212 - The nuclear receptors constitutive androstane receptor and pregnane X receptor cross-talk with hepatic nuclear factor 4alpha to synergistically activate the human CYP2C9 promoter.
Chen Y, Kissling G, Negishi M, Goldstein JA. Chen Y, et al. J Pharmacol Exp Ther. 2005 Sep;314(3):1125-33. doi: 10.1124/jpet.105.087072. Epub 2005 May 26. J Pharmacol Exp Ther. 2005. PMID: 15919766 - Insights into CYP2B6-mediated drug-drug interactions.
Hedrich WD, Hassan HE, Wang H. Hedrich WD, et al. Acta Pharm Sin B. 2016 Sep;6(5):413-425. doi: 10.1016/j.apsb.2016.07.016. Epub 2016 Aug 9. Acta Pharm Sin B. 2016. PMID: 27709010 Free PMC article. Review. - Transcriptional regulation of CYP2C19 and its role in altered enzyme activity.
Uppugunduri CR, Daali Y, Desmeules J, Dayer P, Krajinovic M, Ansari M. Uppugunduri CR, et al. Curr Drug Metab. 2012 Oct;13(8):1196-204. doi: 10.2174/138920012802850146. Curr Drug Metab. 2012. PMID: 22804232 Review.
Cited by
- The nuclear receptors constitutive active/androstane receptor and pregnane x receptor activate the Cyp2c55 gene in mouse liver.
Konno Y, Kamino H, Moore R, Lih F, Tomer KB, Zeldin DC, Goldstein JA, Negishi M. Konno Y, et al. Drug Metab Dispos. 2010 Jul;38(7):1177-82. doi: 10.1124/dmd.110.032334. Epub 2010 Apr 6. Drug Metab Dispos. 2010. PMID: 20371638 Free PMC article. - Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system.
Förster C, Silwedel C, Golenhofen N, Burek M, Kietz S, Mankertz J, Drenckhahn D. Förster C, et al. J Physiol. 2005 Jun 1;565(Pt 2):475-86. doi: 10.1113/jphysiol.2005.084038. Epub 2005 Mar 24. J Physiol. 2005. PMID: 15790664 Free PMC article. - Artemisinin and CYP2A6 activity in healthy subjects.
Asimus S, Hai TN, Van Huong N, Ashton M. Asimus S, et al. Eur J Clin Pharmacol. 2008 Mar;64(3):283-92. doi: 10.1007/s00228-007-0406-1. Epub 2007 Dec 7. Eur J Clin Pharmacol. 2008. PMID: 18064444 Clinical Trial. - Identification of human CYP2C8 as a retinoid-related orphan nuclear receptor target gene.
Chen Y, Coulter S, Jetten AM, Goldstein JA. Chen Y, et al. J Pharmacol Exp Ther. 2009 Apr;329(1):192-201. doi: 10.1124/jpet.108.148916. Epub 2009 Jan 22. J Pharmacol Exp Ther. 2009. PMID: 19164466 Free PMC article. - Regulatory polymorphisms in CYP2C19 affecting hepatic expression.
Sanford JC, Guo Y, Sadee W, Wang D. Sanford JC, et al. Drug Metabol Drug Interact. 2013;28(1):23-30. doi: 10.1515/dmdi-2012-0038. Drug Metabol Drug Interact. 2013. PMID: 23412869 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous